BRY-805

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameBRY-805
Drug Alias NameBRY805BRY-805
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNK cell lectin-like receptor subfamily C member 1 antagonists
TargetsNK cell lectin-like receptor subfamily C member 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHisun Biopharmaceutical Co LtdZhejiang BioRay Biopharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHisun Biopharmaceutical Co Ltd
Inactive CompaniesBioRay Pharmaceutical Co LtdZhejiang BioRay Biopharmaceuticals Co Ltd
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A